John did his graduate studies studying oral streptococci under the supervision of Professor John Tagg at the Department of Microbiology and Immunology, University of Otago in New Zealand. In this work, he identified and characterised bacterial anti-competitor molecules known as bacteriocin’s. Following this, he carried out post-doctoral research at the University of British Columbia (Vancouver, Canada) characterising the mode of action of these molecules and as a Research Fellow at Monash University’s School of Pharmacy (Melbourne, Australia) investigating the modes of resistance bacteria use against antimicrobial peptides. John joined Blis Technologies in 2011. As the Chief Technology Officer he oversees the R&D, Clinical, Regulatory and IP strategies for Blis. He also holds an adjunct Senior Lecturer position with the Department of Microbiology and Immunology, University of Otago, New Zealand.

Sponsored by BLIS Technologies